https://biotechmorning.com/news/syneron-bio-150m-peptide-platform Biotech Morning en 2026-04-03T14:23:19.592Z The Peptide Startup That Just Raised More Than Most Biotechs Are Worth https://biotechmorning.com/news/beam-base-editing-sickle-cell-nejm Biotech Morning en 2026-04-03T14:22:37.143Z The Gene Editor That Rewrites DNA Like a Pencil Just Aced Its Biggest Test https://biotechmorning.com/news/lilly-oral-obesity-pill-fda-approval Biotech Morning en 2026-04-03T14:19:56.945Z Lilly Just Made the Obesity Pill You Don't Need a Needle For https://biotechmorning.com/news/spinraza-high-dose-biogen-sma-fda-approval Biotech Morning en 2026-04-03T14:15:13.429Z Spinraza's Second Act: How a Higher Dose Could Save Biogen's Biggest Franchise https://biotechmorning.com/news/uk-us-pharma-tariff-deal Biotech Morning en 2026-04-03T14:11:10.020Z The UK Just Got a Hall Pass From America's Pharma Tariff Apocalypse https://biotechmorning.com/news/100-percent-tariff-pharma-imports Biotech Morning en 2026-04-03T14:10:24.366Z The 100% Tariff That Could Reshape How America Gets Its Drugs https://biotechmorning.com/news/paradox-mutation-cancer-drug-combination Biotech Morning en 2026-04-02T14:15:32.482Z The Cancer Gene That Breaks Every Rule Just Met Its Match https://biotechmorning.com/news/alto-neuroscience-pde4-inhibitor-schizophrenia-failure Biotech Morning en 2026-04-02T14:14:51.528Z Alto Neuroscience Bet Big on a Brain Patch. It Didn't Stick. https://biotechmorning.com/news/merck-infinimmune-838-million-antibody-deal Biotech Morning en 2026-04-02T14:14:04.999Z Merck Just Bet $838 Million on a Startup That Reads Your Immune System https://biotechmorning.com/news/gilead-hiv-weekly-pill-trial-canceled Biotech Morning en 2026-04-02T14:13:18.556Z Gilead's Weekly HIV Pill Dream Just Hit a Dead End https://biotechmorning.com/news/fda-delays-orca-bio-decision Biotech Morning en 2026-04-02T14:12:39.049Z The FDA Just Put Orca Bio's Big Moment on Ice https://biotechmorning.com/news/korsana-cyclerion-reverse-merger-alzheimers Biotech Morning en 2026-04-02T14:12:00.864Z This $6M Biotech Shell Just Became a $380M Alzheimer's Play Overnight https://biotechmorning.com/news/middle-east-conflict-clinical-trial-disruptions Biotech Morning en 2026-04-02T14:11:12.856Z 8,000 Clinical Trial Sites Just Went Dark in the Middle East https://biotechmorning.com/news/ambrosia-100m-oral-glp1-obesity Biotech Morning en 2026-04-02T14:10:29.214Z Another $100M Bet That You'll Ditch the Needle for a Pill https://biotechmorning.com/news/tyvaso-aces-ipf-trial Biotech Morning en 2026-04-02T14:09:45.187Z A Lung Drug Just Aced a Test It Was Never Built For https://biotechmorning.com/news/immunovant-batoclimab-ted-phase-3-failure Biotech Morning en 2026-04-02T14:08:36.476Z Immunovant's Big Eye Disease Bet Just Went Blind